Profil
Mark W.
Womack currently works at Selexis SA, as Chief Executive Officer from 2022 and BioCina Pty Ltd., as Chief Executive Officer from 2023.
Mr. Womack also formerly worked at KBI Biopharma, Inc., as Chief Executive Officer from 2022 to 2023, OneSource Specialty Pharma Ltd., as Chief Executive Officer, and AGC Biologics, Inc., as Chief Business Officer.
Postes actifs de Mark W. Womack
Sociétés | Poste | Début |
---|---|---|
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Directeur Général | 02/05/2022 |
Anciens postes connus de Mark W. Womack
Sociétés | Poste | Fin |
---|---|---|
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Directeur Général | 17/04/2023 |
Stelis Biopharma Ltd.
Stelis Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Stelis Biopharma Pvt Ltd. develops and manufactures pharmaceutical products. The company was founded in 2007 and is headquartered in Bangalore, India. | Directeur Général | - |
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
AGC Biologics, Inc.
AGC Biologics, Inc. Pharmaceuticals: OtherHealth Technology AGC Biologics, Inc. develops therapeutic proteins for early clinical trials. The firm offers integrated cGMP manufacturing services using microbial fermentation and mammalian cell culture processes. The company was founded in 2007 and is headquartered in Bothell, WA. | Health Technology |
Stelis Biopharma Ltd.
Stelis Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Stelis Biopharma Pvt Ltd. develops and manufactures pharmaceutical products. The company was founded in 2007 and is headquartered in Bangalore, India. | Health Technology |
KBI Biopharma, Inc.
KBI Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services KBI Biopharma, Inc. provides drug development and contract manufacturing services. It helps client partners accelerate and optimize drug development and manufacturing programs by offering an extensive suite of expert development and manufacturing services. The firm offers services to global pharmaceutical and biotechnology companies, and academic and non-profit organizations. The company was founded in 1996 and is headquartered in Durham, NC. | Commercial Services |
Selexis SA
Selexis SA Miscellaneous Commercial ServicesCommercial Services Selexis SA provides research and development services in the field of mammalian cell lines. Its product SUREtechnology Platform improves the way cells are used in the discovery, development and manufacturing of recombinant proteins and drugs. The company was founded by Nicolas Mermod, Igor Edouard Fisch and Peter A. Pfister in 2001 and is headquartered in Plan-les-Ouates, Switzerland. | Commercial Services |